Delivery Order SPE2DB22D2006-SPE2DB25FW1AT
Award Date
5/20/25
Potential Completion Date
5/21/25
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract is for the delivery of OXCARBAZEPINE ER 150 MG TABLET 100S, with a ceiling value of $2,028.63 and a performance period that runs through May 16, 2025. The contract is a firm fixed price, non-set-aside award. Amerisourcebergen Drug Corp holds a...
This federal contract award, with a ceiling value of $2,176.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product OXCARBAZEPINE 300 MG/5 ML SUSP 250ML. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award is a firm fixed price delivery order (SPE2DB24FVD24) worth $1,411.99 issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The delivery order is for the supply of 4564161306 - OXCARBAZEPINE 300 MG/5 ML SUSP 250ML, a pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor on an Indefinite Delivery Contract (IDC) awarded by DLA with a potential value of...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. The firm-fixed-price contract has a ceiling value of $1,324.26 and a completion date of April 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division located in Conshohocken, Pennsylvania. The contract, valued at $1,345.12, is for the provision of 4564249689 - OXCARBAZEPINE 300 MG/5 ML SUSP 250ML, a pharmaceutical product. This delivery order is issued under an existing indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,025.75, is for the delivery of 4564543492 - Oxcarbazepine 300 mg/5 ml suspension, 250 ml. The contract has an ultimate completion date of May 9, 2024 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite...
This federal contract award is for the delivery of 4565602258 OXCARBAZEPINE 300 MG/5 ML SUSP 250ML to the Defense Logistics Agency (DLA). The $1,758.98 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on August 27, 2024 with a completion date of August 28, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles, with a ceiling value of $2,874.78 and a period of performance through April 1, 2025. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite...
This is a delivery order under a Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles, with a ceiling value of $11,218.95 and a completion date of June 18, 2024. This order is not designated as a set-aside contract. AmerisourceBergen holds a large IDC with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $4,564.98 firm fixed-price delivery order is for the supply of the prescription medication oxcarbazepine 300 mg/5 ml suspension. The contract has an ultimate completion date of April 18, 2024. Amerisourcebergen Drug Corp's Corporate Office division is the prime contractor, and the parent company is Cencora, Inc. (doing business as...